Up-to-date on mortality in COPD - report from the OLIN COPD study

BMC Pulmonary Medicine

Volumn 12, Issue , 2012, Pages

  Lindberg, Anne ^a,b   Larsson, Lars Gunnar ^b   Muellerova, Hana ^c   Rönmark, Eva ^a,b   Lundbäck, Bo ^b,d  

^a UMEÅ UNIVERSITY   (Sweden)

^b SUNDERBY HOSPITAL   (Sweden)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH SURVEY; HEART DISEASE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; RISK FACTOR; SMOKING; SPIROMETRY; AGED; MIDDLE AGED; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SWEDEN;

EID: 84855477760     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-12-1     Document Type: Article

References (27)

1. Mathers CD, Loncar D. Updated projections of global mortality and burden of disease, 2002-2030: data sources, methods and results. , http://www.who.int/healthinfo/statistics/bodprojectionspaper.pdf
2. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates. What is the true burden of disease?. Chest 2003, 123:1684-92. 10.1378/chest.123.5.1684, 12740290.
3. Lundbäck B, Lindberg A, Lindstrom M, Rönmark E, Jonsson AC, Jonsson E, Larsson LG, Andersson S, Sandström T, Larsson K. Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003, 97(2):115-22. 10.1053/rmed.2003.1446, 12587960.
4. Lindberg A, Bjerg A, Rönmark E, Larsson LG, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2006, 100(2):264-72. 10.1016/j.rmed.2005.04.029, 15975774.
5. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS. ERS Consensus Statement. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995, 8:1398-1420. 10.1183/09031936.95.08081398, 7489808.
6. Lindström M, Jönsson E, Larsson K, Lundbäck B. Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden. Int J Tuberc Lung Dis 2001, 6(1):74-84.
7. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003, 58:388-93. 10.1136/thorax.58.5.388, 1746680, 12728157.
8. Ekberg-Aronsson M, Pehrson K, Nilsson J-T, Nilsson PM, Löfdahl C-G. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Research 2005, 6:98.
9. Lundbäck B, Eriksson B, Lindberg A, Ekerljung L, Muellerova H, Larsson L-G, Rönmark E. A 20-Year Follow-Up of a Population Study-Based COPD Cohort - Report from the Obstructive Lung Disease in Northern Sweden Studies. COPD: Journal of Chronic Obstructive Pulmonary Disease 2009, 6:263-271. 10.1080/15412550903061483, 19811385.
10. Ryan G, Knuiman MW, Divitini ML, James A, Musk AW, Bartholomew HC. Decline in lung function and mortality; the Busselton Health Study. J Epidemiol Community Health 1999, 53(4):230-4. 10.1136/jech.53.4.230, 1756854, 10396549.
11. Sunyer J, Ulrik CS. Level of FEV1 as a predictor of all-cause and cardiovascular mor-tality: an effect beyond smoking and physical fitness?. Eur Respir J 2005, 25(4):587-8. 10.1183/09031936.05.00011105, 15802327.
12. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular motality: a population-based study and a systematic review of the literature. Chest 2005, 127(6):1952-9. 10.1378/chest.127.6.1952, 15947307.
13. Lundbäck B, Nyström L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal review. Eur Respir J 1991, 4(3):257-66.
14. Lindström M, Kotaniemi J, Jönsson E, Lundbäck B. Smoking, respiratory symptoms and diseases - a comparative study between N Northern Sweden and Northern Finland - Report from the FinEsS study. Chest 2001, 119:852-61. 10.1378/chest.119.3.852, 11243968.
15. Lindberg A, Lundbäck B. The OLIN COPD study. Design, the first year participation and mortality. Clin Respir J 2008, 2:64-71.
16. http://www.goldcopd.com
17. American Thoracic Society Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995, 152(3):1107-36. American Thoracic Society.
18. Berglund E, Birath G, Bjure J, Grimby G, Kjellmer I, Sandqvist L, Söderholm B. Spirometric studies in normal subjects, Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand 1963, 173:185-92.
19. Mannino D, Doherty D, Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006, 100:115-22. 10.1016/j.rmed.2005.03.035, 15893923.
20. Calverley P, Anderson J, Celli B, Ferguson G, Jenkins C, Jones P, Yates J, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Eng J Med 2007, 356:775-89.
21. Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin DP. UPLIFT study Investigators. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. AJRCCM 2009, 180(10):948-55.
22. Bale G, Nartinez-Camblor P, Burge PS, Soriano JB. Long-term mortality follow-up of the ISOLDE participants: causes of death during 13 years after trial completion. Respir Med 2008, 102(10):1468-72. 10.1016/j.rmed.2008.04.001, 18620853.
23. De Marco R, Accordini S, Anto J, Gislason T, Heinrich J, Janson C, Jarvis D, Kunzli N, Leynaert B, Marcon A, Sunyer J, Svanes C, Wjst M, Burney P. Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European Community Respiratory Health Survey. AJRCCM 2009, 108:956-963.
24. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002, 20(5):1117-1122. 10.1183/09031936.02.00023202, 12449163.
25. Pedone C, Scarlata S, Sorino C, Forastiere F, Bellia V, Antonelli-Incalzi R. Does mild COPD affect prognosis in the elderly?. Pulmonary Medicine 2010, 10:35. 10.1186/1471-2466-10-35, 2903556, 20529281., http://www.biomedcentral.com/1471-2466/10/35
26. Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P. Prognostic value of weight change in chronic obstrctive pulmonary disease; results from the Copenhagen City Heart Study. Eur Respir J 2002, 20(3):539-44. 10.1183/09031936.02.00532002, 12358326.
27. Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T, Lindberg E, Brøndum E, Aine T, Bakke P, Jansson C. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med 2007, 101(9):1954-60. 10.1016/j.rmed.2007.04.009, 17532198.